Tranexamic acid for the management of bleeding: a review of the clinical effectiveness and guidelines
CADTH
Record ID 32014000137
English
Authors' recommendations:
Overall, there is evidence to suggest treatment with tranexamic acid reduces mortality from trauma related bleeding. In addition, subgroup analysis suggests treatment with 3 hours of trauma is associated with decreased mortality. However, treatment beyond three hours of trauma may be associated with an increased risk of death.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
http://www.cadth.ca/media/pdf/htis/jul-2013/RC0458%20Tranexamic%20Acid%20final.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Humans
- Tranexamic Acid
- Time Factors
- Survival Rate
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.